“Carl L. Gordon”

a.k.a.:  “Carl L Gordon”,  “Carl L.Gordon”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  4/12/24  as  ↓Signatory

As:  Registrant

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“Carl L. Gordon” has been a Group Member with  2  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
3/21/24		NY	Orbimed Advisors LLC	3	SC 13D/A	MA	Adicet Bio, Inc.
3/19/24			OrbiMed Israel BioFund GP Ltd. Partnership	6	SC 13D/A		BiomX Inc.

“Carl L. Gordon” has/had a Group Member interest in  3  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
3/21/24		MA	Adicet Bio, Inc.	3	SC 13D/A	NY	Orbimed Advisors LLC
3/19/24			BiomX Inc.	4	SC 13D/A		OrbiMed Israel BioFund GP Ltd. Partnership
3/11/24			Chemomab Therapeutics Ltd.	2	SC 13D/A		OrbiMed Israel BioFund GP Ltd. Partnership

“Carl L. Gordon” has been a Group Member with  9  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
3/21/24			Erez Chimovits	9	SC 13D/A	NY	Orbimed Advisors LLC	MA	Adicet Bio, Inc.
			Orbimed Advisors Israel II Ltd.	3
		NY	OrbiMed Capital GP V LLC	3
		NY	OrbiMed Capital GP VI LLC	3
		NY	OrbiMed Genesis GP LLC	3
		•	OrbiMed Israel BioFund GP Limited Partnership	2
			OrbiMed Israel GP II, L.P.	3
			OrbiMed Israel GP Ltd.	9
6/29/23		•	Orbimed Israel Biofund Ltd. Partnership	1	SC 13D/A	NY	Orbimed Advisors LLC	MA	Adicet Bio, Inc.

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Carl L. Gordon” has been a Signatory for/with  17  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
4/12/24		NY	Orbimed Advisors LLC	217	SC 13D/A	PA	Passage BIO, Inc.
3/28/24		CA	Kinnate Biopharma Inc.	1	10-K	—
3/21/24		MA	Compass Therapeutics, Inc.	10	10-K	—
3/19/24			OrbiMed Israel BioFund GP Ltd. Partnership	12	SC 13D/A		BiomX Inc.
3/19/24		MA	Adicet Bio, Inc.	5	10-K	—
12/15/23		MA	Q32 Bio Inc.	1	S-4	—
11/24/23		CA	Foresite Capital Fund V, L.P.	3	SC 13D/A	MA	Theseus Pharmaceuticals, Inc.
3/27/23		CA	Harpoon Therapeutics, Inc.	1	8-K	—
2/14/23		NY	Orbimed Capital LLC	8	SC 13G/A		Milestone Pharmaceuticals Inc.
7/1/22		MA	X4 Pharmaceuticals, Inc.	1	8-K	—
2/23/22		NY	Gordon Carl L	10	4	MA	Compass Therapeutics, Inc.
3/11/20		NY	OrbiMed Capital GP VII LLC	1	3	CO	Enliven Therapeutics, Inc.
6/19/19		NY	OrbiMed Capital GP VI LLC	2	3	NY	Prevail Therapeutics Inc.
2/6/19		NY	OrbiMed Capital GP IV LLC	1	3	CA	Alector, Inc.
7/18/18		NY	OrbiMed Global Healthcare GP LLC	1	3	MA	Constellation Pharmaceuticals Inc.
3/17/17		NY	Isaly Samuel D	1	3	CA	Aadi Bioscience, Inc.
3/17/17		NY	OrbiMed Capital GP V LLC	1	3	CA	Aadi Bioscience, Inc.

“Carl L. Gordon” has/had a Signatory interest in  97  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
4/12/24		PA	Passage BIO, Inc.	4	SC 13D/A	NY	Orbimed Advisors LLC
4/4/24		CO	Enliven Therapeutics, Inc.	3	SC 13D/A	NY	Orbimed Advisors LLC
3/28/24		MA	Q32 Bio Inc.	1	SC 13D	NY	Orbimed Advisors LLC
3/22/24		MA	Compass Therapeutics, Inc.	5	SC 13D/A	NY	Orbimed Advisors LLC
3/21/24		MA	Adicet Bio, Inc.	4	SC 13D/A	NY	Orbimed Advisors LLC
3/19/24			BiomX Inc.	4	SC 13D/A		OrbiMed Israel BioFund GP Ltd. Partnership
3/11/24			Chemomab Therapeutics Ltd.	4	SC 13D/A		OrbiMed Israel BioFund GP Ltd. Partnership
3/8/24		MD	NextCure, Inc.	1	SC 13D/A	NY	Orbimed Advisors LLC
2/21/24		CA	Kinnate Biopharma Inc.	8	SC 13D/A	NY	Orbimed Advisors LLC
2/14/24		CA	Alx Oncology Holdings Inc.	2	SC 13G/A	NY	Orbimed Advisors LLC
2/14/24			InspireMD, Inc.	1	SC 13G	NY	Orbimed Advisors LLC
2/14/24		MA	X4 Pharmaceuticals, Inc.	4	SC 13G/A	NY	Orbimed Advisors LLC
2/14/24		MA	Verastem, Inc.	2	SC 13G/A	NY	Orbimed Advisors LLC
2/14/24		CA	SI-BONE, Inc.	3	SC 13G/A	NY	Orbimed Advisors LLC
2/14/24		MA	Scholar Rock Holding Corp.	1	SC 13G	NY	Orbimed Advisors LLC
2/14/24		NY	Protara Therapeutics, Inc.	3	SC 13G/A	NY	Orbimed Advisors LLC
2/14/24		CA	NeuroPace Inc.	3	SC 13G/A	NY	Orbimed Advisors LLC
2/14/24		MA	Mersana Therapeutics, Inc.	2	SC 13G/A	NY	Orbimed Advisors LLC
2/14/24			Mereo BioPharma Group plc	4	SC 13G/A	NY	Orbimed Advisors LLC
2/14/24		CA	Kezar Life Sciences, Inc.	2	SC 13G/A	NY	Orbimed Advisors LLC
			More...  Please Sign In to list all 97 of them.